Clinical Trials Logo

Filter by:
NCT ID: NCT03829657 Terminated - Clinical trials for Parkinson's Disease (PD)

Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure

REDWOOD
Start date: February 22, 2019
Phase: Phase 3
Study type: Interventional

A Phase 3, 22-week, Multi-center, Randomized Withdrawal Study of ampreloxetine in Treating Symptomatic Neurogenic Orthostatic Hypotension in Subjects with Primary Autonomic Failure

NCT ID: NCT03829618 Terminated - Pneumonia Clinical Trials

Lidocaine Administration During Flexible Bronchoscopy and Endobronchial Ultrasound

Start date: April 1, 2019
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess if there is decrease in cough during flexible bronchoscopy and endobronchial ultrasound when different modes of lidocaine administration are used. The modes of administration being evaluated are topical, nebulized and atomized.

NCT ID: NCT03828929 Terminated - Septic Shock Clinical Trials

Effect of IV Vitamin C, Thiamine, and Steroids on Mortality of Septic Shock

Start date: October 15, 2019
Phase: Phase 3
Study type: Interventional

Preliminary studies show that giving a "cocktail" of intravenous vitamin C, vitamin B1, and steroids to critically ill patients with septic shock may dramatically improve mortality in those patients. These studies suffer from inadequate design due to lack of controls and blinding to prove the causal effect. Our goal is to conduct a prospective blinded randomized control trial to investigate whether this intervention truly effect outcomes.

NCT ID: NCT03828487 Terminated - Clinical trials for Regional Saturation of Oxygen (rSO2)

Performance Comparison of Masimo O3 Regional Oximetry Sensors in Neonates

Start date: December 19, 2018
Phase: N/A
Study type: Interventional

The aim of the study is to compare the performance of the O3 cerebral oximeter and sensor to a 510(k) cleared NIRS (Near-Infrared Spectroscopy) device on neonatal subjects based on data collected from the cutaneously placed forehead sensors. Due to the design of the systems, the devices will be used serially instead of concurrently. Because of this timing, changes in patient state may not be reflected in measurements collected by both devices.

NCT ID: NCT03828448 Terminated - Follicular Lymphoma Clinical Trials

Study to Assess Umbralisib Plus Ublituximab in Participants With Treatment Naïve Follicular Lymphoma

Start date: July 10, 2019
Phase: Phase 2
Study type: Interventional

This is a phase 2, open label study to assess umbralisib in combination with ublituximab in participants with treatment naïve Follicular Lymphoma (FL) and Small Lymphocytic Lymphoma (SLL).

NCT ID: NCT03828136 Terminated - Clinical trials for Symptomatic Cervical Disc Disease

Novum Vitrium® Cervical Cage in Anterior Cervical Discectomy and Fusion

Start date: April 24, 2019
Phase: N/A
Study type: Interventional

A prospective, multicenter, randomized, concurrently controlled, noninferiority clinical trial to compare the safety and effectiveness of instrumented Bio2 Vitrium Cervical Interbody Device in anterior cervical discectomy and fusion (ACDF) with structural allograft bone and local autologous bone graft in treating patients with a symptomatic degenerative cervical disc disease at one level from C3/C4 to C7/T1.

NCT ID: NCT03827993 Terminated - Gynecologic Cancer Clinical Trials

Improving Sexual Health in Gynecologic Cancer Patients

Start date: July 22, 2019
Phase: N/A
Study type: Interventional

This study seeks to find out if an early intervention of providing directed sexual health education and treatment for gynecologic cancer patients will improve patient outcomes as compared to routine clinic visits.

NCT ID: NCT03827564 Terminated - Dry Eye Syndromes Clinical Trials

Goblet Cell Degranulation Produced by Intranasal Tear Neurostimulator (ITN) in Dry Eye Disease

Start date: June 24, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate goblet cell degranulation following acute use of the Intranasal Tear Neurostimulator in participants with dry eye.

NCT ID: NCT03827473 Terminated - Clinical trials for Stage IV Prostate Cancer

Docetaxel or Abiraterone Acetate With ADT in Treating Patients With Metastatic Hormone Sensitive Prostate Cancer

ACADEMIC
Start date: February 8, 2019
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well docetaxel or abiraterone acetate work when combined with androgen deprivation therapy (ADT) in treating patients with hormone sensitive prostate cancer that has spread to other parts of the body. Drugs used in chemotherapy, such as docetaxel and abiraterone acetate, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Antihormone therapy, such as ADT may lessen the amount of androgen made by the body. It is not yet known whether docetaxel or abiraterone acetate work better when combined with ADT in treating patients with hormone sensitive prostate cancer.

NCT ID: NCT03827213 Terminated - Pain Clinical Trials

Exparel Interscalene vs Indwelling Catheter

Start date: January 22, 2019
Phase: Phase 2
Study type: Interventional

The investigators are comparing an indwelling catheter with intermediate duration local anesthetic to a single shot peripheral nerve block with long acting a local anesthetic (Exparel).